Search results
Merck, Kelun-Biotech Ink Licensing Pact For Seven Cancer Candidates
Benzinga via Yahoo Finance· 1 year agoMerck & Co Inc (NYSE: MRK) and Kelun-Biotech (a holding subsidiary of Sichuan Kelun Pharmaceutical...
Merck (MRK) Inks Deal to Develop Antibodies for Treating Cancer
Zacks via Yahoo Finance· 1 year agoMerck (MRK) partners with Kelun-Biotech to develop seven antibody-drug conjugates targeting cancer...
Hong Kong-based biotech Insilico Medicine shifts IPO plan to city from New York
South China Morning Post via Yahoo Finance· 10 months agoHong Kong-based biotech company Insilico Medicine has set its sights on an initial public offering...
GSK adds to ADC dealmaking with second Chinese biotech pact
BioPharma Dive via Yahoo Finance· 5 months agoDive Brief: GSK is deepening its investment in cancer treatments called antibody-drug conjugates,...
China Healthcare Stocks Rally on Hopes for Govt Support
The Wall Street Journal· 2 months agoChinese pharmaceutical stocks rose sharply on hopes for government support, with analysts citing an...
Merck Stock Has Been A Laggard For Seven Months. Is It Staging A Comeback?
Investor's Business Daily· 4 months agoMerck stock is shrugging off seven months of underperformance, shooting more than 7% higher in the...
Chinese AI firm iFlyTek's healthcare unit plans Hong Kong IPO, sparking hopes that spin-offs fuel a...
South China Morning Post via Yahoo Finance· 4 months agoChinese artificial intelligence (AI) company iFlyTek said it plans to spin off its healthcare services subsidiary, iFlyHealth, with a listing in Hong Kong. Shenzhen-listed iFlyTek said the initial ...